PRKN and diabetes mellitus: During streptozotocin (STZ)‐induced diabetes stress in pancreatic β‐cells, Foxo3a inhibits Parkin‐mediated mitochondrial recruitment and mitophagy, thereby impacting the growth of pancreatic β‐cells and insulin secretion.45